Cellebrite DI (CLBT) Set to Announce Quarterly Earnings on Thursday

Cellebrite DI (NASDAQ:CLBTGet Free Report) is scheduled to post its quarterly earnings results before the market opens on Thursday, February 15th. Analysts expect Cellebrite DI to post earnings of $0.05 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Cellebrite DI (NASDAQ:CLBTGet Free Report) last posted its quarterly earnings data on Tuesday, November 14th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.08. Cellebrite DI had a negative net margin of 19.40% and a positive return on equity of 119.62%. The business had revenue of $84.20 million during the quarter, compared to the consensus estimate of $82.13 million. During the same quarter last year, the company posted ($0.01) earnings per share. The firm’s quarterly revenue was up 17.4% compared to the same quarter last year. On average, analysts expect Cellebrite DI to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cellebrite DI Stock Performance

NASDAQ CLBT opened at $9.28 on Tuesday. The company has a market capitalization of $1.75 billion, a PE ratio of -30.06, a price-to-earnings-growth ratio of 0.73 and a beta of 1.44. Cellebrite DI has a 52-week low of $4.87 and a 52-week high of $9.57. The company has a 50-day simple moving average of $8.63 and a 200 day simple moving average of $7.94.

Hedge Funds Weigh In On Cellebrite DI

A number of large investors have recently modified their holdings of the company. Morgan Stanley raised its stake in shares of Cellebrite DI by 53,737.4% during the fourth quarter. Morgan Stanley now owns 2,144,884 shares of the company’s stock worth $9,352,000 after acquiring an additional 2,140,900 shares in the last quarter. Blair William & Co. IL boosted its holdings in Cellebrite DI by 3,021.1% in the first quarter. Blair William & Co. IL now owns 523,978 shares of the company’s stock valued at $3,353,000 after acquiring an additional 507,190 shares in the last quarter. BlackRock Inc. boosted its holdings in Cellebrite DI by 43.7% in the first quarter. BlackRock Inc. now owns 480,017 shares of the company’s stock valued at $2,923,000 after acquiring an additional 146,057 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Cellebrite DI by 157.6% in the second quarter. Renaissance Technologies LLC now owns 197,300 shares of the company’s stock valued at $1,421,000 after acquiring an additional 120,700 shares in the last quarter. Finally, State Street Corp boosted its holdings in Cellebrite DI by 52.4% in the second quarter. State Street Corp now owns 236,821 shares of the company’s stock valued at $1,208,000 after acquiring an additional 81,381 shares in the last quarter. 21.80% of the stock is currently owned by institutional investors.

About Cellebrite DI

(Get Free Report)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the United States, and the Asia-Pacific. Its DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.

Further Reading

Earnings History for Cellebrite DI (NASDAQ:CLBT)

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.